In contrast, although a mortality benefit has been found for the early detection of prostate cancer using prostate specific antigen (PSA) testing [5], this form of screening is not recommended by the Australian Government because the harms outweigh the benefits [5,6]. Here, KLK3 is linked to prostate cancer.